Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study.

ABSTRACT:

Purpose

The SAGIT® instrument, designed to assist clinicians to stage acromegaly, assess treatment response and adapt patient management, was well received by endocrinologists in a pilot study. We report an interim analysis of baseline data from the validation phase.

Methods

The SAGIT® validation study (ClinicalTrials.gov NCT02539927) is an international, non-interventional study. Data collection included: demographic/disease characteristics; medical/surgical histories; concomitant acromegaly treatments; investigators' subjective evaluation of disease-control status (clinical global evaluation of disease control [CGE-DC]; controlled/not controlled/yet to be clarified) and clinical disease activity (active/not active); growth hormone (GH) and insulin-like growth factor-1 (IGF

SUBMITTER: Giustina A 

PROVIDER: S-EPMC6728296 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature